Pennsylvania Turnpike Commission's 2011A Revenue Bonds Rated 'A+'; Other Ratings Assigned Mar 11

  • ID: 1790959
  • March 2011
  • Region: Pennsylvania
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) March 14, 2011-- Standard & Poor's Ratings Services has assigned its 'A+' rating to the Pennsylvania Turnpike Commission's (PTC) turnpike revenue bonds, series 2011A. At the same time, Standard & Poor's assigned its 'SP-1+' short-term rating to the 2012 maturity and its 'A+' rating to the 2013-2015 maturities of the commission's floating rate notes (SIFMA-indexed) series 2011B. In addition, Standard & Poor's affirmed its 'A+' underlying rating (SPUR) on the commission's turnpike's approximately $2.8 billion revenue bonds outstanding and its 'A-' SPUR on the approximately $2.9 billion subordinate revenue bonds outstanding. Standard & Poor's also affirmed its 'A+/A-1' rating on PTC's series 2010A bonds. The rating's long-term component reflects the creditworthiness of the obligor (the...

Companies mentioned in this report are:
- Pennsylvania Tpk Comm

Action: Affirmed
Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Pennsylvania Tpk Comm

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.